Wei Yan
Impact in
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
- Immune cells in cancer
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
Papers in
- Aging 3
- Hepatology 12
- Liver Diseases and Immunity 7
Wei Yan
85 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 119
- Immunology 803
- Cancer Research 471
- Hepatology 224
- Clinical Biochemistry 181
- Aging 43
Countries citing papers authored by Wei Yan
This map shows the geographic impact of Wei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yan more than expected).
Fields of papers citing papers by Wei Yan
This network shows the impact of papers produced by Wei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yan. The network helps show where Wei Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 22 | |
| 7 | 2022 | 71 | |
| 8 | 2022 | 8 | |
| 9 | 2021 | 30 | |
| 10 | 2020 | 87 | |
| 11 | 2020 | 47 | |
| 12 | 2019 | 8 | |
| 13 | 2019 | 4 | |
| 14 | 2018 | 29 | |
| 15 | 2012 | 10 | |
| 16 | 2011 | 288 | |
| 17 | 2008 | 25 | |
| 18 | 2008 | 11 | |
| 19 | 2008 | 59 | |
| 20 | [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity]. | 2004 | 2 |
About Wei Yan
Wei Yan is a scholar working on Aging, Hepatology, Cancer Research, Immunology and Molecular Biology, having authored 91 papers that have together received 2.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (9 papers), Reproductive Biology and Fertility (9 papers), Liver Diseases and Immunity (7 papers), RNA modifications and cancer (6 papers), Inflammasome and immune disorders (6 papers), Immune Response and Inflammation (6 papers), Hepatitis B Virus Studies (5 papers) and Axon Guidance and Neuronal Signaling (5 papers). The work is most often cited by research in Immunology (803 citations), Cancer Research (471 citations), Hepatology (224 citations), Clinical Biochemistry (181 citations) and Aging (43 citations). Wei Yan has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Dean Tian, Allan Tsung, Yu Fu, Hai Huang, Ping Han, Mei Liu, Su Zhou, Michael T. Lotze, John Evankovich and Charles T. Esmon. Their work appears in journals such as Frontiers in Immunology, Hepatology, International Immunopharmacology, PLoS ONE and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.